Congressman’s Stock Sale Draws Scrutiny

A Republican congressman with direct oversight of Medicare policy sold his entire UnitedHealth Group stake, valued at up to half a million dollars, just weeks before the stock plummeted more than 9%. The perfectly timed sale by Rep. Kevin Hern (R-OK), who sits on the House Health Subcommittee and received privileged briefings from the Centers for Medicare and Medicaid Services (CMS), has raised serious questions about congressional access to nonpublic information and the fairness of a two-tiered market

Story Highlights

  • Rep. Kevin Hern (R-OK) sold his entire UnitedHealth position valued at $250,001–$500,000 on December 23, 2025, before shares tanked.
  • The sale came weeks before UNH stock dropped more than 9% following news of flat Medicare payment rates for 2027.
  • Hern sits on the House Health Subcommittee that oversees Medicare policy and received CMS briefings before the holiday recess.
  • The timing highlights ongoing concerns about congressional access to nonpublic information while managing personal stock portfolios.

Perfectly Timed Exit Raises Eyebrows

Rep. Kevin Hern sold his entire UnitedHealth Group holdings through his family trust on December 23, 2025, liquidating a position worth between $250,001 and $500,000. The Oklahoma Republican disclosed the transaction on January 22, 2026, just days before UNH shares plunged more than 9% on January 26 following a Wall Street Journal report revealing the White House planned to keep Medicare Advantage payment rates flat for 2027. Hern serves on the House Ways and Means Health Subcommittee, which directly oversees Medicare payment policy and maintains regular communication with the Centers for Medicare and Medicaid Services.

The timing appears remarkable considering Hern had steadily accumulated UNH shares over three years, making 12 separate purchases between October 2021 and July 2024. His decision to exit the position entirely came just before CMS briefed congressional leaders on upcoming Medicare rate decisions ahead of the December recess. While retail investors absorbed substantial losses when the stock tanked, Hern had already converted his shares to cash. The contrast between what committee members knew and what ordinary investors understood has sparked frustration among those who lack access to policy briefings that could signal market-moving developments.

Part of Broader Pattern Among Lawmakers

Hern’s sale fits within a troubling pattern of congressional stock trades in UnitedHealth during 2025, as the company faced mounting regulatory pressure from Department of Justice investigations and congressional scrutiny over Medicare billing practices and care denials. Throughout 2025, lawmakers collectively sold up to $1.2 million in UNH stock compared to $950,000 in purchases, with sales accelerating after DOJ civil and criminal probes became public. Representatives from both parties, including Reps. Khanna, Cisneros, Shreve, Taylor, Moskowitz, and Bresnahan, divested UNH holdings as regulatory headwinds intensified.

Portfolio manager Weiskopf from Tidal Financial characterized these lawmaker sales as “red flags” that should alert regular investors to regulatory concerns invisible to the public. The bipartisan nature of the selloff demonstrates how committee assignments provide access to briefings unavailable to constituents. Some lawmakers who sold UNH stock, including Reps. Johnson and Landsman, have publicly supported banning congressional stock trading to eliminate conflicts of interest. The practice allows members of Congress who write healthcare policy to simultaneously profit from or avoid losses in healthcare company stocks, creating an inherent tension between public duty and personal financial interest.

Constitutional Concerns About Two-Tiered Markets

This situation exemplifies how government overreach into markets creates unfair advantages for those in power while punishing ordinary Americans. The Constitution established limited government precisely to prevent officials from leveraging their positions for personal gain at the expense of citizens. When lawmakers receive privileged briefings on policy changes that will move markets, then trade ahead of public announcements, it undermines the fundamental principle of equal justice under law. Retail investors operating without access to CMS briefings suffered significant losses on January 26, while Hern had already exited his position based on information unavailable to the public.

The lack of restrictions on congressional trading stands in stark contrast to rules governing corporate insiders, who face strict prohibitions on trading based on material nonpublic information. Members of Congress who oversee industries can legally trade stocks in those same sectors despite possessing policy insights that could predict market reactions. This double standard erodes public trust in government institutions and creates justified resentment among hardworking Americans who play by different rules than their elected representatives. Whether Hern acted on specific briefing information or merely exercised caution given his committee role, the optics reinforce perceptions of a rigged system favoring Washington insiders over Main Street investors.

Interestingly, UNH shares have since rebounded more than 9% from their January lows, outperforming the broader market and complicating accusations of perfect insider timing. Analysts maintain a “Moderate Buy” rating with price targets ranging from $386 to $430, noting potential regulatory tailwinds despite near-term headwinds from ACA rebates and rising medical costs. The stock’s recovery suggests Hern may have sold prematurely if his goal was maximizing returns, though he successfully avoided the immediate post-announcement selloff. Questions remain about what information committee members received during pre-recess CMS briefings and whether that knowledge influenced trading decisions, highlighting why many conservatives support banning congressional stock ownership in sectors under their direct oversight to restore accountability and fairness to American markets.

Sources:

RELATED ARTICLESMORE FROM AUTHOR

Latest on The Conservative View

© 2026 The Conservative View.
All Rights Reserved.